| Clinically significant inaccurate localization of lesions with PET/CT: frequency in 300 patients MM Osman, C Cohade, Y Nakamoto, LT Marshall, JP Leal, RL Wahl Journal of Nuclear Medicine 44 (2), 240-243, 2003 | 338 | 2003 |
| Normal FDG distribution patterns in the head and neck: PET/CT evaluation Y Nakamoto, M Tatsumi, D Hammoud, C Cohade, MM Osman, RL Wahl Radiology 234 (3), 879-885, 2005 | 312 | 2005 |
| Respiratory motion artifacts on PET emission images obtained using CT attenuation correction on PET-CT MM Osman, C Cohade, Y Nakamoto, RL Wahl European journal of nuclear medicine and molecular imaging 30, 603-606, 2003 | 307 | 2003 |
| [18F] FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung M Mamede, T Higashi, M Kitaichi, K Ishizu, T Ishimori, Y Nakamoto, ... Neoplasia 7 (4), 369-379, 2005 | 293 | 2005 |
| Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis M Tatsumi, C Cohade, Y Nakamoto, RL Wahl Radiology 229 (3), 831-837, 2003 | 281 | 2003 |
| Relationship between retention index in dual-phase 18F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer T Higashi, T Saga, Y Nakamoto, T Ishimori, MH Mamede, M Wada, R Doi, ... Journal of Nuclear Medicine 43 (2), 173-180, 2002 | 271 | 2002 |
| Delayed 18F‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas Y Nakamoto, T Higashi, H Sakahara, N Tamaki, M Kogire, R Doi, ... Cancer 89 (12), 2547-2554, 2000 | 271 | 2000 |
| 111In oxine labelled mesenchymal stem cell SPECT after intravenous administration in myocardial infarction BB Chin, Y Nakamoto, JW Bulte, MF Pittenger, R Wahl, DL Kraitchman Nuclear medicine communications 24 (11), 1149-1154, 2003 | 260 | 2003 |
| PET/CT: comparison of quantitative tracer uptake between germanium and CT transmission attenuation-corrected images Y Nakamoto, M Osman, C Cohade, LT Marshall, JM Links, S Kohlmyer, ... Journal of Nuclear Medicine 43 (9), 1137-1143, 2002 | 230 | 2002 |
| Clinical value of positron emission tomography with FDG for recurrent ovarian cancer Y Nakamoto, T Saga, T Ishimori, M Mamede, K Togashi, T Higuchi, ... American Journal of Roentgenology 176 (6), 1449-1454, 2001 | 207 | 2001 |
| Initial experience with oral contrast in PET/CT: phantom and clinical studies C Cohade, M Osman, Y Nakamoto, LT Marshall, JM Links, EK Fishman, ... Journal of Nuclear Medicine 44 (3), 412-416, 2003 | 202 | 2003 |
| Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET)—Usefulness and limitations in “clinical reality”— T Higashi, T Saga, Y Nakamoto, T Ishimori, K Fujimoto, R Doi, M Imamura, ... Annals of nuclear medicine 17, 261-279, 2003 | 185 | 2003 |
| Increased 18F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation T Ishimori, T Saga, M Mamede, H Kobayashi, T Higashi, Y Nakamoto, ... Journal of Nuclear Medicine 43 (5), 658-663, 2002 | 185 | 2002 |
| 3D‐micro‐MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with reference to their pharmacokinetic properties H Kobayashi, N Sato, A Hiraga, T Saga, Y Nakamoto, H Ueda, J Konishi, ... Magnetic Resonance in Medicine: An Official Journal of the International …, 2001 | 185 | 2001 |
| FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors T Higashi, N Tamaki, T Torizuka, Y Nakamoto, H Sakahara, T Kimura, ... Journal of Nuclear Medicine 39 (10), 1727-1735, 1998 | 183 | 1998 |
| Direct Comparison of FDG PET and CT Findings in Patients with Lymphoma: Initial Experience1 M Tatsumi, C Cohade, Y Nakamoto, EK Fishman, RL Wahl Radiology 237 (3), 1038-1045, 2005 | 174 | 2005 |
| Effects of nonionic intravenous contrast agents at PET/CT imaging: phantom and canine studies Y Nakamoto, BB Chin, DL Kraitchman, LP Lawler, LT Marshall, RL Wahl Radiology 227 (3), 817-824, 2003 | 162 | 2003 |
| Tumor targeting and imaging of intraperitoneal tumors by use of antisense oligo-DNA complexed with dendrimers and/or avidin in mice N Sato, H Kobayashi, T Saga, Y Nakamoto, T Ishimori, K Togashi, ... Clinical cancer research 7 (11), 3606-3612, 2001 | 153 | 2001 |
| Establishment and characterization of a breast cancer cell line expressing Na+/I− symporters for radioiodide concentrator gene therapy Y Nakamoto, T Saga, T Misaki, H Kobayashi, N Sato, T Ishimori, S Kosugi, ... Journal of Nuclear Medicine 41 (11), 1898-1904, 2000 | 148 | 2000 |
| Utility of FDG PET/CT in IgG4-related systemic disease K Nakatani, Y Nakamoto, K Togashi Clinical radiology 67 (4), 297-305, 2012 | 144 | 2012 |
